Related Experiment Video
Updated: Apr 28, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Controlled delivery of inhaled therapeutic agents
1RTI International, 3040 Cornwallis Road, Research Triangle Park, NC 27709, USA.
Abstract:
There is increasing interest in the delivery of drugs to the lungs to treat a variety of diseases. The spatial and temporal influence of deposition and clearance mechanisms on the fate of inhaled materials are important factors in the control of delivery of therapeutic agents to the lungs. Balancing anatomical and physiological considerations with pharmaceutical properties dictates the therapeutic potential of any pharmacological and immunological strategy. A brief introduction of aerosol properties and inhaler technology is followed by considerations of in vitro and in vivo disposition in the context of controlled drug release for achieving anatomical, physiological and therapeutic targeting. Comprehensive assessment of drug delivery to, and disposition from, the lungs is required if controlled and targeted strategies are to be successful.
Related Concept Videos
Inhaled Medications
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Inhalational Anesthetics: Overview

